{"id":"placebo-patch-and-pill","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo)"}]},"_chembl":{"chemblId":"CHEMBL1628401","moleculeType":"Small molecule","molecularWeight":"657.81"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo products are inert formulations designed to be indistinguishable from active drugs in appearance and administration route. They work through psychological and psychosomatic mechanisms, including expectation, conditioning, and the ritual of treatment. Placebo patches and pills are primarily used in clinical research as control comparators to isolate the true pharmacological effects of investigational drugs.","oneSentence":"A placebo formulation (patch and pill) that produces therapeutic effects through the patient's expectation and the placebo effect rather than active pharmacological mechanisms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:17.720Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control comparator in clinical trials (not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT05538910","phase":"NA","title":"Defining Neurobiological Links Between Substance Use and Mental Illness","status":"RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2023-02-02","conditions":"Major Depressive Disorder, Substance Use Disorder, Normal Physiology","enrollment":620},{"nctId":"NCT06065670","phase":"PHASE1, PHASE2","title":"Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-09-15","conditions":"Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion","enrollment":44},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT04112368","phase":"PHASE4","title":"Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2020-09-15","conditions":"Suicidal Ideation","enrollment":124},{"nctId":"NCT03740204","phase":"PHASE2","title":"The Role of Estrogen in the Neurobiology of Eating Disorders","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2019-06-13","conditions":"Eating Disorders, Hypoestrogenemia","enrollment":120},{"nctId":"NCT03018366","phase":"PHASE2","title":"Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2017-01-01","conditions":"Estrogen Deficiency, Cardiovascular Disease (CVD), Functional Hypothalamic Amenorrhea","enrollment":29},{"nctId":"NCT03467789","phase":"PHASE1","title":"Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2018-10-01","conditions":"Basal Cell Carcinoma, Basal Cell Nevus Syndrome","enrollment":37},{"nctId":"NCT01511614","phase":"NA","title":"Nicotine Withdrawal Symptoms and Smoking Relapse","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2013-05-20","conditions":"Nicotine Dependence","enrollment":112},{"nctId":"NCT00775463","phase":"PHASE2","title":"Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine","status":"COMPLETED","sponsor":"United Therapeutics","startDate":"2009-05","conditions":"Systemic Sclerosis, Scleroderma","enrollment":148},{"nctId":"NCT03176784","phase":"PHASE4","title":"UW Quitting Using Intensive Treatment Study (QUITS)","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2017-11-11","conditions":"Tobacco Dependence","enrollment":1251},{"nctId":"NCT03498313","phase":"PHASE4","title":"Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2018-07-27","conditions":"Suicidal Ideation","enrollment":60},{"nctId":"NCT00088153","phase":"PHASE2, PHASE3","title":"Effects of Anorexia Nervosa on Bone Mass in Adolescents","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2003-07","conditions":"Anorexia Nervosa","enrollment":110},{"nctId":"NCT02859142","phase":"PHASE4","title":"Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2018-03-29","conditions":"Smoking Cessation, Alcohol Drinking","enrollment":122},{"nctId":"NCT00946192","phase":"PHASE3","title":"Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-05","conditions":"Exercise-related Amenorrhea","enrollment":121},{"nctId":"NCT01944423","phase":"EARLY_PHASE1","title":"Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine","status":"COMPLETED","sponsor":"University of Texas at Austin","startDate":"2013-10","conditions":"Nicotine Addiction, Panic Attack","enrollment":53},{"nctId":"NCT01208324","phase":"NA","title":"Estrogen and Serotonin on Changing Brain Chemistry","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2010-03-04","conditions":"Menopause","enrollment":47},{"nctId":"NCT02351167","phase":"PHASE4","title":"Genetically Informed Smoking Cessation Trial","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2015-05-20","conditions":"Smoking Cessation","enrollment":822},{"nctId":"NCT02367833","phase":"PHASE4","title":"Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis","status":"COMPLETED","sponsor":"Penn State University","startDate":"2015-01","conditions":"Bone; Disorder, Development and Growth","enrollment":60},{"nctId":"NCT00744328","phase":"PHASE4","title":"Postpartum Depression: Transdermal Estradiol Versus Sertraline","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2008-08","conditions":"Postpartum Depression","enrollment":85},{"nctId":"NCT00086411","phase":"PHASE2","title":"Comparing Smoking Treatment Programs for Lighter Smokers - 1","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2003-09","conditions":"Tobacco Use Disorder","enrollment":260},{"nctId":"NCT02042196","phase":"EARLY_PHASE1","title":"Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2013-12","conditions":"Menopause, Aging","enrollment":100},{"nctId":"NCT03720847","phase":"PHASE4","title":"Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2016-12-31","conditions":"Suicidal Ideation","enrollment":30},{"nctId":"NCT00565916","phase":"NA","title":"Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2004-08","conditions":"Postmenopausal Syndrome","enrollment":22},{"nctId":"NCT00756275","phase":"NA","title":"Varenicline and Motivational Advice for Smokers With Substance Use Disorders","status":"COMPLETED","sponsor":"Brown University","startDate":"2009-01","conditions":"Smoking Cessation, Nicotine Dependence","enrollment":158},{"nctId":"NCT00066157","phase":"PHASE2, PHASE3","title":"Alzheimer's Disease: Therapeutic Potential of Estrogen","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2001-09","conditions":"Alzheimer Disease","enrollment":42},{"nctId":"NCT00223717","phase":"PHASE1","title":"Treatment of Supine Hypertension in Autonomic Failure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2001-01","conditions":"Hypertension","enrollment":152},{"nctId":"NCT01308814","phase":"PHASE2, PHASE3","title":"Perimenopausal Estrogen Replacement Therapy Study","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2010-10","conditions":"Perimenopause, Menopause, Depression","enrollment":172},{"nctId":"NCT00755716","phase":"PHASE3","title":"Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study","status":"COMPLETED","sponsor":"UConn Health","startDate":"2006-04","conditions":"Tobacco Dependence","enrollment":57},{"nctId":"NCT00591305","phase":"NA","title":"New Therapy of Laryngeal Papilloma In Children","status":"TERMINATED","sponsor":"Boston University","startDate":"2007-09","conditions":"Papilloma","enrollment":1},{"nctId":"NCT02524561","phase":"NA","title":"KEEPS Mammographic Density And Breast Health Ancillary Study","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2005-09","conditions":"Mammographic Density, Abnormal Mammogram","enrollment":517},{"nctId":"NCT00087880","phase":"PHASE2","title":"Maintaining Abstinence in Chronic Cigarette Smokers - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2002-12","conditions":"Tobacco Use Disorder","enrollment":407},{"nctId":"NCT01074554","phase":"PHASE1, PHASE2","title":"Trial of Antimycobacterial Therapy in Sarcoidosis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2010-02","conditions":"Sarcoidosis","enrollment":30},{"nctId":"NCT00320697","phase":"PHASE4","title":"Smoking Relapse Prevention in Schizophrenia","status":"COMPLETED","sponsor":"North Suffolk Mental Health Association","startDate":"2006-04","conditions":"Schizophrenia, Schizoaffective Disorder, Smokers","enrollment":25},{"nctId":"NCT01314001","phase":"PHASE3","title":"Pharmacogenetics of Nicotine Addiction Treatment","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-12","conditions":"Nicotine Addiction","enrollment":1246},{"nctId":"NCT00414453","phase":"PHASE4","title":"Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis","status":"TERMINATED","sponsor":"University of Rochester","startDate":"2007-01","conditions":"Neuropathic Pain, Chronic Pain, Multiple Sclerosis","enrollment":19},{"nctId":"NCT01048944","phase":"PHASE4","title":"Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers","status":"COMPLETED","sponsor":"Southern Illinois University Carbondale","startDate":"2005-06","conditions":"Nicotine Dependence","enrollment":197},{"nctId":"NCT00659737","phase":"NA","title":"Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"Drexel University College of Medicine","startDate":"2008-04","conditions":"Nausea, Vomiting","enrollment":115},{"nctId":"NCT00154180","phase":"PHASE4","title":"Kronos Early Estrogen Prevention Study (KEEPS)","status":"UNKNOWN","sponsor":"Kronos Longevity Research Institute","startDate":"2005-09","conditions":"Menopause, Arteriosclerosis","enrollment":728}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"marketed","status":"active","brandName":"Placebo patch and pill","genericName":"Placebo patch and pill","companyName":"Massachusetts General Hospital","companyId":"massachusetts-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo formulation (patch and pill) that produces therapeutic effects through the patient's expectation and the placebo effect rather than active pharmacological mechanisms. Used for Control comparator in clinical trials (not a therapeutic indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}